Published in Diabetes Metab on December 01, 2001
Molecular processes that handle -- and mishandle -- dietary lipids. J Clin Invest (2008) 1.60
Type 2 diabetes in mice induces hepatic overexpression of sulfatase 2, a novel factor that suppresses uptake of remnant lipoproteins. Hepatology (2010) 0.92
The latest on the effect of prior exercise on postprandial lipaemia. Sports Med (2013) 0.84
Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group. Lancet (1998) 6.17
Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes. Lancet (1995) 2.29
The effect of the gastrointestinal lipase inhibitor, orlistat, on serum lipids and lipoproteins in patients with primary hyperlipidaemia. Eur J Clin Pharmacol (1994) 2.04
Documentation of hyperglucagonemia throughout the day in nonobese and obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab (1987) 1.96
Open questions about metabolically normal obesity. Int J Obes (Lond) (2010) 1.83
Effect of long chain triglyceride infusion on glucose metabolism in man. Metabolism (1982) 1.79
Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes. Diabetes (1987) 1.76
Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes. J Clin Invest (1997) 1.71
Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein, K-45. Identity of K-45 with paraoxonase. Eur J Biochem (1993) 1.57
Promoter polymorphisms of human paraoxonase PON1 gene and serum paraoxonase activities and concentrations. Arterioscler Thromb Vasc Biol (2000) 1.53
Relationship between peripheral vascular disease and high plantar pressures in diabetic neuro-ischaemic patients. Diabetes Metab (2003) 1.41
Energy expenditure and substrates oxidative patterns, after glucose, fat or mixed load in normal weight subjects. Eur J Clin Nutr (1997) 1.39
Pathways from obesity to diabetes. Int J Obes Relat Metab Disord (2002) 1.36
Toxicologic evaluation of FK 506. Transplant Proc (1990) 1.36
Resistance to insulin suppression of plasma free fatty acid concentrations and insulin stimulation of glucose uptake in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab (1987) 1.24
Glucose-induced thermogenesis in nondiabetic and diabetic obese subjects. Diabetes (1982) 1.23
Paraoxonase promoter polymorphism T(-107)C and relative paraoxonase deficiency as determinants of risk of coronary artery disease. J Mol Med (Berl) (2001) 1.18
Mycobacterium haemophilum causing perihilar or cervical lymphadenitis in healthy children. J Pediatr (1992) 1.17
Characterization of subpopulations of lipoprotein particles isolated from human cerebrospinal fluid. Biochim Biophys Acta (1995) 1.16
Quantification of human serum paraoxonase by enzyme-linked immunoassay: population differences in protein concentrations. Biochem J (1994) 1.15
Gait characteristics of diabetic patients: a systematic review. Diabetes Metab Res Rev (2008) 1.13
Natural history and physiological determinants of changes in glucose tolerance in a non-diabetic population: the RISC Study. Diabetologia (2011) 1.13
Daily moderate alcohol consumption increases serum paraoxonase activity; a diet-controlled, randomised intervention study in middle-aged men. Atherosclerosis (1999) 1.12
Two alleles of the human paraoxonase gene produce different amounts of mRNA. An explanation for differences in serum concentrations of paraoxonase associated with the (Leu-Met54) polymorphism. Arterioscler Thromb Vasc Biol (1997) 1.12
Decreased stability of the M54 isoform of paraoxonase as a contributory factor to variations in human serum paraoxonase concentrations. J Lipid Res (2001) 1.12
Risk factors associated with contrast sensitivity loss in diabetic patients. Graefes Arch Clin Exp Ophthalmol (1996) 1.10
Randomised controlled trial of a guided self-help treatment on the Internet for binge eating disorder. Behav Res Ther (2011) 1.09
Persistent pupillary membrane in basenji dogs. Vet Rec (1991) 1.08
The gait and balance of patients with diabetes can be improved: a randomised controlled trial. Diabetologia (2009) 1.08
Serum paraoxonase is reduced in type 1 diabetic patients compared to non-diabetic, first degree relatives; influence on the ability of HDL to protect LDL from oxidation. Atherosclerosis (2001) 1.08
2-Amino-4-phosphonobutyric acid as a glutamate antagonist on locust muscle. Nature (1976) 1.06
Insulin resistance, lipid and fatty acid concentrations in 867 healthy Europeans. European Group for the Study of Insulin Resistance (EGIR). Eur J Clin Invest (2000) 1.05
Effect of obesity on ambient plasma glucose, free fatty acid, insulin, growth hormone, and glucagon concentrations. J Clin Endocrinol Metab (1986) 1.02
A monoclonal anti-idiotypic antibody against anti-receptor antibodies from myasthenic sera. Eur J Immunol (1982) 1.02
Impaired glucose tolerance and diabetes in obesity: a 6-year follow-up study of glucose metabolism. Metabolism (1990) 1.01
Energy economy hampers body weight loss after gastric bypass. J Clin Endocrinol Metab (2000) 1.01
Factors affecting the in-vitro development to blastocysts of bovine oocytes matured and fertilized in vitro. J Reprod Fertil (1991) 1.00
Relationships between plasma-free fatty acid concentration, endogenous glucose production, and fasting hyperglycemia in normal and non-insulin-dependent diabetic individuals. Metabolism (1987) 0.99
Factors influencing energy intake and body weight loss after gastric bypass. Eur J Clin Nutr (2002) 0.98
Insulin suppression of plasma-free fatty acid concentration in normal individuals and patients with type 2 (non-insulin-dependent) diabetes. Diabetologia (1987) 0.98
Metabolic normality in overweight and obese subjects. Which parameters? Which risks? Int J Obes (Lond) (2011) 0.98
Effect of differences in glucose tolerance on insulin's ability to regulate carbohydrate and free fatty acid metabolism in obese individuals. J Clin Endocrinol Metab (1986) 0.96
Evaluation of a guided internet self-treatment programme for bulimia nervosa in several European countries. Eur Eat Disord Rev (2010) 0.95
Regulation of glucose storage in obesity and diabetes: metabolic aspects. Diabetes Metab Rev (1988) 0.95
Decreased glucose-induced thermogenesis after weight loss in obese subjects: a predisposing factor for relapse of obesity? Am J Clin Nutr (1984) 0.95
Effect of beta and alpha adrenergic blockade on glucose-induced thermogenesis in man. J Clin Invest (1984) 0.94
Differential effects of low density lipoproteins on insulin-like growth factor-1 (IGF-1) and IGF-1 receptor expression in vascular smooth muscle cells. J Biol Chem (2000) 0.94
The impact of callosities on the magnitude and duration of plantar pressure in patients with diabetes mellitus. A callus may cause 18,600 kilograms of excess plantar pressure per day. Diabetes Metab (2002) 0.93
Effect of weight loss on glucose disposal in obese and obese diabetic patients. Int J Obes (1985) 0.92
Association of fasting glucagon and proinsulin concentrations with insulin resistance. Diabetologia (2007) 0.92
Upregulation of peroxisome proliferator-activated receptor gamma coactivator gene (PGC1A) during weight loss is related to insulin sensitivity but not to energy expenditure. Diabetologia (2007) 0.91
Insulin action and non-esterified fatty acids. The European Group for the Study of Insulin Resistance (EGIR). Proc Nutr Soc (1997) 0.90
Evidence for diminished brain 5-hydroxytryptamine biosynthesis in obese diabetic and non-diabetic humans. Am J Clin Nutr (1985) 0.90
Uncoupling protein-3 expression in skeletal muscle and free fatty acids in obesity. Lancet (1998) 0.90
Association of elevated lipoprotein(a) levels and coronary heart disease in NIDDM patients. Relationship with apolipoprotein(a) phenotypes. Diabetologia (1994) 0.89
Investigation of standing balance in diabetic patients with and without peripheral neuropathy using accelerometers. Clin Biomech (Bristol, Avon) (2009) 0.89
Monoclonal antibodies directed against the neurotransmitter binding site of nicotinic acetylcholine receptor. FEBS Lett (1980) 0.89
A new table for prevention of hypoglycaemia during physical activity in type 1 diabetic patients. Diabetes Metab (2004) 0.89
Study on lipid metabolism in obesity diabetes. Metabolism (1984) 0.88
Metformin treatment leads to an increase in basal, but not insulin-stimulated, glucose disposal in obese patients with impaired glucose tolerance. Diabet Med (1999) 0.88
Impact of body fat mass extent on cardiac autonomic alterations in women. Eur J Clin Invest (2009) 0.88
Interaction of lipid and carbohydrate metabolism after infusions of lipids or of lipid lowering agents: lack of a direct relationship between free fatty acid concentrations and glucose disposal. Diabete Metab (1992) 0.87
Heterogeneity in the properties of the trypanolytic factor in normal human serum. Mol Biochem Parasitol (1994) 0.87
An exercise intervention to improve diabetic patients' gait in a real-life environment. Gait Posture (2010) 0.86
Plantar pressure distribution in Type 2 diabetic patients without peripheral neuropathy and peripheral vascular disease. Diabet Med (2005) 0.86
Persistent correlation of ghrelin plasma levels with body mass index both in stable weight conditions and during gastric-bypass-induced weight loss. Obes Surg (2008) 0.85
Obesity: a complex growing challenge. Exp Clin Endocrinol Diabetes (2009) 0.85
Regulation of nutrient metabolism and energy expenditure. Metabolism (1995) 0.85
Lack of thermogenic response to glucose/insulin infusion in diabetic obese subjects. Int J Obes (1986) 0.84
Iron-ascorbic acid-induced oxidant stress and its quenching by paraoxonase 1 in HDL and the liver: comparison between humans and rats. J Cell Biochem (2005) 0.84
[Rimonabant improves cardiometabolic risk profile in obese or overweight subjects: overview of RIO studies]. Rev Med Suisse (2006) 0.84
Impact of lifestyle intervention on body weight and the metabolic syndrome in home-care providers. Diabetes Metab (2012) 0.84
Aspirin use is associated with higher serum concentrations of the anti-oxidant enzyme, paraoxonase-1. Diabetologia (2003) 0.83
Acute hyperinsulinemia and very-low-density and low-density lipoprotein subfractions in obese subjects. Am J Clin Nutr (2000) 0.83
Physical activity and fat-free and fat mass by bioelectrical impedance in 3853 adults. Med Sci Sports Exerc (2001) 0.83
Clinical factors associated with gait alterations in diabetic patients. Diabet Med (2009) 0.83
Efficacy of rimonabant in obese patients with binge eating disorder. Exp Clin Endocrinol Diabetes (2012) 0.82
Gender-based dimorphic pattern for interleukin-1 receptor antagonist in type 2 diabetes mellitus. Diabetes Metab (2008) 0.82
Reliability of diabetic patients' gait parameters in a challenging environment. Gait Posture (2008) 0.82
Cognitive distortions in obese patients with or without eating disorders. Eat Weight Disord (2006) 0.82
High density lipoprotein (HDL) metabolism in noninsulin-dependent diabetes mellitus: measurement of HDL turnover using tritiated HDL. J Clin Endocrinol Metab (1987) 0.82
[About 10 cases of Launois-Bensaude disease]. Ann Chir Plast Esthet (2008) 0.82
Comparison of metabolic effects of white beans processed into two different physical forms. Diabetes Care (1986) 0.81
[Understanding obesity in Africa: the effect of [economic] development and [mental] concepts]. Rev Med Suisse (2014) 0.81
HDL particle associated proteins in plasma and cerebrospinal fluid: identification and partial sequencing. Appl Theor Electrophor (1988) 0.81
Biofeedback for foot offloading in diabetic patients with peripheral neuropathy. Diabet Med (2010) 0.81
Contrast sensitivity in obese dyslipidemic patients with insulin resistance. Arch Ophthalmol (1998) 0.81
Distribution of apolipoprotein E between free and A-II complexed forms in very-low- and high-density lipoproteins: functional implications. Biochim Biophys Acta (1991) 0.81
Associations between HDL oxidation and paraoxonase-1 and paraoxonase-1 gene polymorphisms in families affected by familial combined hyperlipidemia. Nutr Metab Cardiovasc Dis (2004) 0.81
European Lipoprotein Club: report of the 20th annual conference, Tutzing, 8-11 September 1997. Atherosclerosis (1998) 0.81
Evaluation of a psycho-educational nutritional program in diabetic patients. Patient Educ Couns (2001) 0.81
Beneficial effect of hormone replacement therapy on weight loss in obese menopausal women. Maturitas (1999) 0.81
Modulation by blood glucose levels of activity and concentration of paraoxonase in young patients with type 1 diabetes mellitus. Metabolism (2001) 0.81
Patient education in Switzerland: from diabetes to chronic diseases. Patient Educ Couns (2001) 0.80